We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS IPROS One of the largest technical database sites in Japan that collects information on.

medicine×マーケットリサーチセンター - List of Manufacturers, Suppliers, Companies and Products

medicine Product List

151~165 item / All 448 items

Displayed results

[Research Material] Global Market for Rare Neurological Disease Treatments

Global Market for Rare Neurological Disease Treatments: Biologics, Organic Compounds, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

This research report (Global Rare Neurological Disease Treatment Market) investigates and analyzes the current state and outlook for the global market for rare neurological disease treatments over the next five years. It includes information on the overview of the global rare neurological disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the rare neurological disease treatment market focus on biopharmaceuticals and organic compounds, while the segments by application target hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments calculate the market size for rare neurological disease treatments by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the rare neurological disease treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Malignant Glioma Therapeutics

Global Market for Malignant Glioma Treatment Drugs: Alkylating Agents, VEGF/VEGFR Inhibitors, Anti-Angiogenesis Drugs, Hospitals, Cancer Research Institutions, Diagnostic Centers, Others

This research report (Global Malignant Glioma Drugs Market) investigates and analyzes the current state and outlook for the global market of malignant glioma treatment drugs over the next five years. It includes information on the overview of the global malignant glioma treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include alkylating agents, VEGF/VEGFR inhibitors, and anti-angiogenic drugs, while the segments by application target hospitals, cancer research institutions, diagnostic centers, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for malignant glioma treatment drugs. It also includes the market share of major companies in the malignant glioma treatment drugs sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Morquio Syndrome Treatment

Global Market for Morquio Syndrome Treatment: Morquio A, Morquio B, Hospitals, Clinics, Others

This research report (Global Morquio Syndrome Treatment Market) investigates and analyzes the current state and future outlook of the global market for Morquio syndrome treatment over the next five years. It includes information on the overview of the global Morquio syndrome treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on Morquio A and Morquio B, while the segments by application target hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Morquio syndrome treatment. It also includes the market share of major companies in Morquio syndrome treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Terbinafine Hydrochloride Medication

World Market for Terbinafine Hydrochloride: Topical, Oral, Nail Infections, Toenail Infections, Others

This research report (Global Terbinafine Hydrochloride Drug Market) investigates and analyzes the current status and outlook for the global terbinafine hydrochloride drug market over the next five years. It includes information on the overview of the global terbinafine hydrochloride drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on topical and oral forms, while the segments by application target nail infections, toenail infections, and others. The regional segments calculate the market size of terbinafine hydrochloride drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the terbinafine hydrochloride drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Gene Therapy Medicine

World Market for Gene Therapy Medicine: Oral, Injection, Cancer, Monogenic, Infectious Diseases, Cardiovascular Diseases, Others

This research report (Global Gene Therapy Medicine Market) investigates and analyzes the current state and future outlook of the global gene therapy medicine market over the next five years. It includes information on the overview of the global gene therapy medicine market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on oral and injection methods, while the segments by application target cancer, monogenic diseases, infectious diseases, cardiovascular diseases, and others. The regional segments calculate the market size of gene therapy medicine by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in gene therapy medicine, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Head and Neck Cancer Treatment Drugs/Treatments

Head and neck cancer treatment drugs/treatment global market: PD inhibitors, microtubule inhibitors, EGFR inhibitors, surgery, radiation therapy, chemotherapy, immunotherapy.

This research report (Global Head and Neck Cancer Drugs/Therapeutics Market) investigates and analyzes the current status and outlook for the global market of head and neck cancer treatment drugs/therapeutics over the next five years. It includes information on the overview of the global head and neck cancer treatment drugs/therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the head and neck cancer treatment drugs/therapeutics market focus on PD inhibitors, microtubule inhibitors, and EGFR inhibitors, while the segments by application target surgery, radiation therapy, chemotherapy, and immunotherapy. The regional segments calculate the market size for head and neck cancer treatment drugs/therapeutics by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the head and neck cancer treatment drugs/therapeutics market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Amlodipine Besylate

World Market for Amlodipine Besylate: 2.5mg, 5mg, 10mg, Hypertension, Heart Disease

This research report (Global Amlodipine Besylate Market) investigates and analyzes the current state and outlook for the global market of amlodipine besylate over the next five years. It includes information on the overview of the global amlodipine besylate market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the amlodipine besylate market focus on 2.5mg, 5mg, and 10mg, while the segments by application target hypertension and heart disease. The regional segments calculate the market size of amlodipine besylate by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the amlodipine besylate market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Gout Treatment Drugs

World Market for Gout Treatment Drugs: NSAIDs, Corticosteroids, Colchicine, Uric Acid Lowering Drugs, Acute Gout, Chronic Gout

This research report (Global Gout Therapeutics Market) investigates and analyzes the current status and outlook for the global market for gout therapeutics over the next five years. It includes information on the overview of the global gout therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include NSAIDs, corticosteroids, colchicine, and urate-lowering drugs, while the segments by application focus on acute gout and chronic gout. The regional segments calculate the market size for gout therapeutics by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in gout therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Fabry Disease Treatment

Global Market for Fabry Disease Treatment: Enzyme Replacement Therapy (ERT), Chaperone Therapy, Substrate Reduction Therapy (SRT), Others, Hospitals, Clinics, Others

This research report (Global Fabry Disease Treatment Market) investigates and analyzes the current status and outlook for the global Fabry disease treatment market over the next five years. It includes information on the overview of the global Fabry disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Fabry disease treatment market include enzyme replacement therapy (ERT), chaperone therapy, substrate reduction therapy (SRT), and others, while the segments by application include hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Fabry disease treatment. It also includes the market share of major companies in Fabry disease treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Kidney Cancer & Renal Cell Carcinoma (RCC) Treatment Drugs

World Market for Kidney Cancer & Renal Cell Carcinoma (RCC) Treatment Drugs: Afinitor (Everolimus), Avastin (Bevacizumab), Cabomety...

This research report (Global Kidney Cancer and Renal Cell Carcinoma (RCC)) investigates and analyzes the current status and outlook for the global market of kidney cancer and renal cell carcinoma (RCC) treatment drugs over the next five years. It includes information on the overview of the global kidney cancer and renal cell carcinoma (RCC) treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Afinitor (everolimus), Avastin (bevacizumab), Cabometyx (cabozantinib), Inlyta (axitinib), Nexavar (sorafenib), Proleukin (aldesleukin), Torisel (temsirolimus), Sutent (sunitinib), and Votrient (pazopanib). The segments by application target hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Stomach Cancer Treatment

Global Market for Stomach Cancer Treatment: Programmed Cell Death Protein 1 (PD-1) Inhibitors, Human Epidermal Growth Factor Receptor (HER2) Antagonists, Vascular Endothelial ...

This research report (Global Stomach Cancer and Gastric Cancer Treatment Market) investigates and analyzes the current state of the global stomach cancer treatment market and its outlook for the next five years. It includes information on the overview of the global stomach cancer treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the stomach cancer treatment market include Programmed Cell Death Protein 1 (PD-1) inhibitors, Human Epidermal Growth Factor Receptor 2 (HER2) antagonists, Vascular Endothelial Growth Factor Receptor (VEGFR) antagonists, and others. The segments by application focus on hospitals and clinics. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for stomach cancer treatment. It also includes the market share of major companies in stomach cancer treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Merkel Cell Carcinoma Treatment

World Market for Merkel Cell Carcinoma Treatment: Chemotherapy, Immunotherapy, Combination Therapy, Others, Hospitals, Outpatient Surgery Centers, Others

This research report (Global Merkel Cell Carcinoma Treatment Market) investigates and analyzes the current state and future outlook of the global market for Merkel cell carcinoma treatment over the next five years. It includes information on the overview of the global Merkel cell carcinoma treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Merkel cell carcinoma treatment market include chemotherapy, immunotherapy, combination therapy, and others, while the segments by application include hospitals, outpatient surgical centers, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for Merkel cell carcinoma treatment. It also includes the market share of major companies in the Merkel cell carcinoma treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Systemic Infectious Disease Treatment

Global Market for Systemic Infection Treatment: Oral, Intravenous, Local, Hospital, Clinic, Others

This research report (Global Systemic Infection Therapy Market) investigates and analyzes the current status and outlook for the global market for systemic infection treatment over the next five years. It includes information on the overview of the global systemic infection treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the systemic infection treatment market focus on oral, intravenous, and topical treatments, while the segments by application target hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for systemic infection treatment. It also includes the market share of major companies in systemic infection treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for IBS Treatment

Global Market for IBS Treatment: IBS-D, IBS-C, IBS-M, Hospitals, Clinics, Research Institutes

This research report (Global IBS Treatment Market) investigates and analyzes the current state of the global IBS treatment market and its outlook for the next five years. It includes information on the overview of the global IBS treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the IBS treatment market focus on IBS-D, IBS-C, and IBS-M, while the segments by application target hospitals, clinics, and laboratories. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for IBS treatment. It also includes the market share of major companies in the IBS treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Biosimilar Treatments

Global Market for Biosimilar Treatments: Recombinant Non-Glycosylated Proteins, Recombinant Glycosylated Proteins, Recombinant Peptides, Oncology, Chronic ...

This research report (Global Biosimilars Treatment Market) investigates and analyzes the current state and outlook for the global biosimilars treatment market over the next five years. It includes information on the overview of the global biosimilars treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the biosimilars treatment market focus on recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides, while the segments by application target oncology, chronic and autoimmune diseases, blood disorders, growth hormone disorders, and infectious diseases. The regional segments calculate the market size for biosimilars treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. The report also includes the market share of major companies in the biosimilars treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine